Skip to main content
logo
Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
20.11
-0.56 (-2.71%)
At close: Sep 18, 2026, 4:00 PM EDT
20.02
-0.09 (-0.45%)
After-hours: Sep 18, 2026, 7:30 PM EDT

Sarepta Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-136.73-713.41235.24-535.98-703.49-418.78
Depreciation & Amortization
44.7144.5237.7244.441.8638.02
Loss (Gain) From Sale of Assets
----102--102
Loss (Gain) From Sale of Investments
-37.512-40.28-15.86-8.084.39
Stock-Based Compensation
98.81123.4184.3182.51233.02113.94
Other Operating Activities
274.34249.9793.83407.02150.8119.43
Change in Accounts Receivable
150.47203.76-201.66-185.7-61.64-51.65
Change in Inventory
-94.39-301.09-395.17-147.71-50.78-83.77
Change in Accounts Payable
-47.85104.27110.65-50.14147.5723.3
Change in Unearned Revenue
-175.1772.05-32.16-86.83-89.24-89.24
Change in Other Net Operating Assets
34.31-0.94-198.26-10.7114.62103.2
Operating Cash Flow
111.01-205.48-205.79-500.99-325.35-443.17
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-29.16-101.97-136.96-76.11-30.82-38.49
Sale (Purchase) of Intangibles
-6.88-7.88-1090.76-1.4399.69
Investment in Securities
136.88179.49902.52-180.46-1,015434.21
Investing Cash Flow
100.8569.64755.56-165.8-1,047495.41

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
----1,127-
Long-Term Debt Repaid
--162.59-0.07--823.23-
Net Debt Issued (Repaid)
-159.07-162.59-0.07-304.17-
Issuance of Common Stock
21.7638.779.5351.2530.04569.33
Repurchase of Common Stock
--25.01----7.77
Other Financing Activities
-19.45-19.4545.3573.76-101.7-
Financing Cash Flow
-156.76-168.34124.81125232.51561.57

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
55.1-304.18674.58-541.79-1,140613.81

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
81.85-307.45-342.74-577.1-356.17-481.66
Free Cash Flow Growth
------
Free Cash Flow Margin
4.15%-13.99%-18.02%-46.41%-38.17%-68.62%
Free Cash Flow Per Share
0.79-3.07-3.18-6.25-4.07-5.93
Levered Free Cash Flow
22.1495.92-432.21-330.11-54.65-8.7
Unlevered Free Cash Flow
66.91119.75-420.71-316.36-21.3731.01

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
31.7714.9115.8615.9244.4255.95
Cash Income Tax Paid
27.0137.6322.5915.081.70.58
Change in Working Capital
-132.6378.04-716.61-481.09-39.47-98.17
SEC Filings: 10-K · 10-Q